+Open data
-Basic information
Entry | Database: EMDB / ID: EMD-23719 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Title | EBOV GP bound to rEBOV-442 and rEBOV-515 Fabs | |||||||||
Map data | Mucin deleted Ebola virus GP (Makona variant) in complex with rEBOV-442 and rEBOV-515 Fabs. | |||||||||
Sample |
| |||||||||
Function / homology | Filoviruses glycoprotein, extracellular domain / Filoviruses glycoprotein / Filovirus glycoprotein / Envelope glycoprotein GP2-like, HR1-HR2 / extracellular region / membrane / Virion spike glycoprotein / Virion spike glycoprotein Function and homology information | |||||||||
Biological species | Ebola virus / Homo sapiens (human) | |||||||||
Method | single particle reconstruction / cryo EM / Resolution: 3.9 Å | |||||||||
Authors | Murin CD / Ward AB | |||||||||
Funding support | United States, 2 items
| |||||||||
Citation | Journal: Cell / Year: 2021 Title: Pan-ebolavirus protective therapy by two multifunctional human antibodies. Authors: Pavlo Gilchuk / Charles D Murin / Robert W Cross / Philipp A Ilinykh / Kai Huang / Natalia Kuzmina / Viktoriya Borisevich / Krystle N Agans / Joan B Geisbert / Seth J Zost / Rachel S Nargi / ...Authors: Pavlo Gilchuk / Charles D Murin / Robert W Cross / Philipp A Ilinykh / Kai Huang / Natalia Kuzmina / Viktoriya Borisevich / Krystle N Agans / Joan B Geisbert / Seth J Zost / Rachel S Nargi / Rachel E Sutton / Naveenchandra Suryadevara / Robin G Bombardi / Robert H Carnahan / Alexander Bukreyev / Thomas W Geisbert / Andrew B Ward / James E Crowe / Abstract: Ebolaviruses cause a severe and often fatal illness with the potential for global spread. Monoclonal antibody-based treatments that have become available recently have a narrow therapeutic spectrum ...Ebolaviruses cause a severe and often fatal illness with the potential for global spread. Monoclonal antibody-based treatments that have become available recently have a narrow therapeutic spectrum and are ineffective against ebolaviruses other than Ebola virus (EBOV), including medically important Bundibugyo (BDBV) and Sudan (SUDV) viruses. Here, we report the development of a therapeutic cocktail comprising two broadly neutralizing human antibodies, rEBOV-515 and rEBOV-442, that recognize non-overlapping sites on the ebolavirus glycoprotein (GP). Antibodies in the cocktail exhibited synergistic neutralizing activity, resisted viral escape, and possessed differing requirements for their Fc-regions for optimal in vivo activities. The cocktail protected non-human primates from ebolavirus disease caused by EBOV, BDBV, or SUDV with high therapeutic effectiveness. High-resolution structures of the cocktail antibodies in complex with GP revealed the molecular determinants for neutralization breadth and potency. This study provides advanced preclinical data to support clinical development of this cocktail for pan-ebolavirus therapy. | |||||||||
History |
|
-Structure visualization
Movie |
Movie viewer |
---|---|
Structure viewer | EM map: SurfViewMolmilJmol/JSmol |
Supplemental images |
-Downloads & links
-EMDB archive
Map data | emd_23719.map.gz | 7.6 MB | EMDB map data format | |
---|---|---|---|---|
Header (meta data) | emd-23719-v30.xml emd-23719.xml | 16.5 KB 16.5 KB | Display Display | EMDB header |
FSC (resolution estimation) | emd_23719_fsc.xml | 14.6 KB | Display | FSC data file |
Images | emd_23719.png | 111.6 KB | ||
Archive directory | http://ftp.pdbj.org/pub/emdb/structures/EMD-23719 ftp://ftp.pdbj.org/pub/emdb/structures/EMD-23719 | HTTPS FTP |
-Validation report
Summary document | emd_23719_validation.pdf.gz | 353.9 KB | Display | EMDB validaton report |
---|---|---|---|---|
Full document | emd_23719_full_validation.pdf.gz | 353.5 KB | Display | |
Data in XML | emd_23719_validation.xml.gz | 12.1 KB | Display | |
Data in CIF | emd_23719_validation.cif.gz | 16.1 KB | Display | |
Arichive directory | https://ftp.pdbj.org/pub/emdb/validation_reports/EMD-23719 ftp://ftp.pdbj.org/pub/emdb/validation_reports/EMD-23719 | HTTPS FTP |
-Related structure data
Related structure data | 7m8lMC M: atomic model generated by this map C: citing same article (ref.) |
---|---|
Similar structure data |
-Links
EMDB pages | EMDB (EBI/PDBe) / EMDataResource |
---|---|
Related items in Molecule of the Month |
-Map
File | Download / File: emd_23719.map.gz / Format: CCP4 / Size: 125 MB / Type: IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annotation | Mucin deleted Ebola virus GP (Makona variant) in complex with rEBOV-442 and rEBOV-515 Fabs. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Projections & slices | Image control
Images are generated by Spider. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Voxel size | X=Y=Z: 1.03 Å | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Density |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Symmetry | Space group: 1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Details | EMDB XML:
CCP4 map header:
|
-Supplemental data
-Sample components
-Entire : Complex of mucin deleted Ebola virus GP (Makona variant) bound to...
Entire | Name: Complex of mucin deleted Ebola virus GP (Makona variant) bound to rEBOV-442 and rEBOV-515 Fabs |
---|---|
Components |
|
-Supramolecule #1: Complex of mucin deleted Ebola virus GP (Makona variant) bound to...
Supramolecule | Name: Complex of mucin deleted Ebola virus GP (Makona variant) bound to rEBOV-442 and rEBOV-515 Fabs type: complex / ID: 1 / Parent: 0 / Macromolecule list: #1-#6 |
---|---|
Source (natural) | Organism: Ebola virus |
Recombinant expression | Organism: Homo sapiens (human) |
-Macromolecule #1: Virion spike glycoprotein 1
Macromolecule | Name: Virion spike glycoprotein 1 / type: protein_or_peptide / ID: 1 / Number of copies: 3 / Enantiomer: LEVO |
---|---|
Source (natural) | Organism: Ebola virus |
Molecular weight | Theoretical: 34.978613 KDa |
Recombinant expression | Organism: Homo sapiens (human) |
Sequence | String: MDAMKRGLCC VLLLCGAVFV SPSQEIHARF RRGARSIPLG VIHNSTLQVS DVDKLVCRDK LSSTNQLRSV GLNLEGNGVA TDVPSVTKR WGFRSGVPPK VVNYEAGEWA ENCYNLEIKK PDGSECLPAA PDGIRGFPRC RYVHKVSGTG PCAGDFAFHK E GAFFLYDR ...String: MDAMKRGLCC VLLLCGAVFV SPSQEIHARF RRGARSIPLG VIHNSTLQVS DVDKLVCRDK LSSTNQLRSV GLNLEGNGVA TDVPSVTKR WGFRSGVPPK VVNYEAGEWA ENCYNLEIKK PDGSECLPAA PDGIRGFPRC RYVHKVSGTG PCAGDFAFHK E GAFFLYDR LASTVIYRGT TFAEGVVAFL ILPQAKKDFF SSHPLREPVN ATEDPSSGYY STTIRYQATG FGTNETEYLF EV DNLTYVQ LESRFTPQFL LQLNETIYAS GKRSNTTGKL IWKVNPEIDT TIGEWAFWET KKNLTRKIRS EELSFT |
-Macromolecule #2: rEBOV-442 Fab heavy chain
Macromolecule | Name: rEBOV-442 Fab heavy chain / type: protein_or_peptide / ID: 2 / Number of copies: 3 / Enantiomer: LEVO |
---|---|
Source (natural) | Organism: Homo sapiens (human) |
Molecular weight | Theoretical: 25.179199 KDa |
Recombinant expression | Organism: Homo sapiens (human) |
Sequence | String: EVQLVESGGG LVKPGGSLRL SCTGSGGTGF TFKYAGMSWV RQAPGKGPEW IGRIKSRIDG GTTDYAAPVK DRFIVSRDDS RNTLYLQMN SLKTEDTAVY YCATGSGKGP SASFGESYYY YDFINVWGKG TTVTVSSAST KGPSVFPLAP SSKSTSGGTA A LGCLVKDY ...String: EVQLVESGGG LVKPGGSLRL SCTGSGGTGF TFKYAGMSWV RQAPGKGPEW IGRIKSRIDG GTTDYAAPVK DRFIVSRDDS RNTLYLQMN SLKTEDTAVY YCATGSGKGP SASFGESYYY YDFINVWGKG TTVTVSSAST KGPSVFPLAP SSKSTSGGTA A LGCLVKDY FPEPVTVSWN SGALTSGVHT FPAVLQSSGL YSLSSVVTVP SSSLGTQTYI CNVNHKPSNT KVDKKVEPKS C |
-Macromolecule #3: rEBOV-442 Fab light chain
Macromolecule | Name: rEBOV-442 Fab light chain / type: protein_or_peptide / ID: 3 / Number of copies: 3 / Enantiomer: LEVO |
---|---|
Source (natural) | Organism: Homo sapiens (human) |
Molecular weight | Theoretical: 23.715314 KDa |
Recombinant expression | Organism: Homo sapiens (human) |
Sequence | String: ESVLTQSPGT LSLSPGERAT LSCRASQSIS RKYLAWYQQK PGQAPRLLIY GSSSRATGIP DRFSGSGSGT DFTLTISRLE PEDFAVYYC HQYESSPWTF GQGTKVEIKR TVAAPSVFIF PPSDEQLKSG TASVVCLLNN FYPREAKVQW KVDNALQSGN S QESVTEQD ...String: ESVLTQSPGT LSLSPGERAT LSCRASQSIS RKYLAWYQQK PGQAPRLLIY GSSSRATGIP DRFSGSGSGT DFTLTISRLE PEDFAVYYC HQYESSPWTF GQGTKVEIKR TVAAPSVFIF PPSDEQLKSG TASVVCLLNN FYPREAKVQW KVDNALQSGN S QESVTEQD SKDSTYSLSS TLTLSKADYE KHKVYACEVT HQGLRSPVTK SFNRGEC |
-Macromolecule #4: Virion spike glycoprotein 2
Macromolecule | Name: Virion spike glycoprotein 2 / type: protein_or_peptide / ID: 4 / Number of copies: 3 / Enantiomer: LEVO |
---|---|
Source (natural) | Organism: Ebola virus |
Molecular weight | Theoretical: 22.158592 KDa |
Recombinant expression | Organism: Homo sapiens (human) |
Sequence | String: NNNTHHQDTG EESASSGKLG LITNTIAGVA GLITGGRRTR REVIVNAQPK CNPNLHYWTT QDEGAAIGLA WIPYFGPAAE GIYTEGLMH NQDGLICGLR QLANETTQAL QLFLRATTEL RTFSILNRKA IDFLLQRWGG TCHILGPDCC IEPHDWTKNI T DKIDQIIH ...String: NNNTHHQDTG EESASSGKLG LITNTIAGVA GLITGGRRTR REVIVNAQPK CNPNLHYWTT QDEGAAIGLA WIPYFGPAAE GIYTEGLMH NQDGLICGLR QLANETTQAL QLFLRATTEL RTFSILNRKA IDFLLQRWGG TCHILGPDCC IEPHDWTKNI T DKIDQIIH DDDDKAGWSH PQFEKGGGSG GGSGGGSWSH PQFEK |
-Macromolecule #5: rEBOV-515 Fab heavy chain
Macromolecule | Name: rEBOV-515 Fab heavy chain / type: protein_or_peptide / ID: 5 / Number of copies: 3 / Enantiomer: LEVO |
---|---|
Source (natural) | Organism: Homo sapiens (human) |
Molecular weight | Theoretical: 24.047846 KDa |
Recombinant expression | Organism: Homo sapiens (human) |
Sequence | String: QVQLHESGPG LVKPSQTLSL TCTVSGGSIN SAGYYWTWIR QHPGKGLEWI GYIDYTGRTY YNPSLESRVI ISIDTSKNHF SLRLTSVSA ADTAVYYCAR ESSWVSELGR DNWGQGTLVT VSSASTKGPS VFPLAPSSKS TSGGTAALGC LVKDYFPEPV T VSWNSGAL ...String: QVQLHESGPG LVKPSQTLSL TCTVSGGSIN SAGYYWTWIR QHPGKGLEWI GYIDYTGRTY YNPSLESRVI ISIDTSKNHF SLRLTSVSA ADTAVYYCAR ESSWVSELGR DNWGQGTLVT VSSASTKGPS VFPLAPSSKS TSGGTAALGC LVKDYFPEPV T VSWNSGAL TSGVHTFPAV LQSSGLYSLS SVVTVPSSSL GTQTYICNVN HKPSNTKVDK KVEPKSC |
-Macromolecule #6: rEBOV-515 Fab light chain
Macromolecule | Name: rEBOV-515 Fab light chain / type: protein_or_peptide / ID: 6 / Number of copies: 3 / Enantiomer: LEVO |
---|---|
Source (natural) | Organism: Homo sapiens (human) |
Molecular weight | Theoretical: 23.528092 KDa |
Recombinant expression | Organism: Homo sapiens (human) |
Sequence | String: EIVMTQSPAT LPVSPGEGAT LSCRASQSVF TNLAWYQQKP GQAPRLLIYD ASTRATGIPA RFSGSGSGTE FTLTISSLQS EDFAVYYCQ QYNNWPRTYG QGTRVEVKRT VAAPSVFIFP PSDEQLKSGT ASVVCLLNNF YPREAKVQWK VDNALQSGNS Q ESVTEQDS ...String: EIVMTQSPAT LPVSPGEGAT LSCRASQSVF TNLAWYQQKP GQAPRLLIYD ASTRATGIPA RFSGSGSGTE FTLTISSLQS EDFAVYYCQ QYNNWPRTYG QGTRVEVKRT VAAPSVFIFP PSDEQLKSGT ASVVCLLNNF YPREAKVQWK VDNALQSGNS Q ESVTEQDS KDSTYSLSST LTLSKADYEK HKVYACEVTH QGLRSPVTKS FNRGEC |
-Macromolecule #9: 2-acetamido-2-deoxy-beta-D-glucopyranose
Macromolecule | Name: 2-acetamido-2-deoxy-beta-D-glucopyranose / type: ligand / ID: 9 / Number of copies: 6 / Formula: NAG |
---|---|
Molecular weight | Theoretical: 221.208 Da |
Chemical component information | ChemComp-NAG: |
-Experimental details
-Structure determination
Method | cryo EM |
---|---|
Processing | single particle reconstruction |
Aggregation state | particle |
-Sample preparation
Buffer | pH: 7.4 |
---|---|
Vitrification | Cryogen name: ETHANE |
-Electron microscopy
Microscope | FEI TITAN KRIOS |
---|---|
Image recording | Film or detector model: GATAN K2 SUMMIT (4k x 4k) / Average electron dose: 50.0 e/Å2 |
Electron beam | Acceleration voltage: 300 kV / Electron source: FIELD EMISSION GUN |
Electron optics | Illumination mode: FLOOD BEAM / Imaging mode: BRIGHT FIELD |
Experimental equipment | Model: Titan Krios / Image courtesy: FEI Company |